
eIF4A3-IN-1q
CAS No. 2132392-89-1
eIF4A3-IN-1q( —— )
Catalog No. M13396 CAS No. 2132392-89-1
A potent, subtype-selective, orally available eIF4A3 inhibitor with IC50 of 0.14 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameeIF4A3-IN-1q
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, subtype-selective, orally available eIF4A3 inhibitor with IC50 of 0.14 uM.
-
DescriptionA potent, subtype-selective, orally available eIF4A3 inhibitor with IC50 of 0.14 uM; displays no activity against eIF4A1, eIF4A2, BRR2 and DHX29 (IC50>100 uM); upregulates SC35 1.6 kb mRNA expression by 8-fold at 3 uM and 20-fold at 10 uM, potently inhibit cell growth in HCT-116 cells (GI50=1.18 uM) ; shows antitumor efficacy and promising PK profiles in vivo, without severe body weight loss.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNuclear Receptor/Transcription Factor
-
TargeteIF
-
RecptoreIF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2132392-89-1
-
Formula Weight645.861
-
Molecular FormulaC29H21BrClF3N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CN(C(CN1C(=O)C2=CN(C(=O)C(=C2)C(F)(F)F)C3=CC=CC=C3)C4=CC=C(C=C4)Cl)C(=O)C5=NC=C(C=C5)Br
-
Chemical Name(S)-5-(4-(5-bromopicolinoyl)-3-(4-chlorophenyl)piperazine-1-carbonyl)-1-phenyl-3-(trifluoromethyl)pyridin-2(1H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mizojiri R, et al. ACS Med Chem Lett. 2017 Sep 8;8(10):1077-1082.
molnova catalog



related products
-
2BAct
2BAct (eIF2B activator 2BAct) is a novel, highly selective, CNS-permeable small molecule eIF2B activator with EC50 of 33 nM in cell-based reporter assays.
-
eIF4A3-IN-2
eIF4A3-IN-2 is an allosteric, selective, non-competitive eIF4A3 inhibitor with IC50 of 0.11 uM.
-
SBI-0640756
SBI-0640756 (SBI-756) is a first-in-class inhibitor that targets eIF4G1 and disrupts the eIF4F complex.